Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women who have been diagnosed with endometrial (uterine lining) cancer and are being seen at MD Anderson Cancer Center or its Houston-area locations
- Women who have been diagnosed with abnormal uterine bleeding or endometrial hyperplasia (a thickening of the uterine lining) and are being seen at MD Anderson Cancer Center or its Houston-area locations
- Women who have not been diagnosed with endometrial cancer or endometrial hyperplasia
- Women who are at least 18 years old
- Women who are able to read, write, and speak English
- Women who are willing and able to sign a written consent form agreeing to take part
Who may not be able to join:
- No specific exclusion criteria have been listed for this trial (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Larissa Meyer, MD, M.D. Anderson Cancer Center
Phone: (713) 745-0973
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Patient education
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.